GlaxoSmithKline (GB:GSK) has released an update.
GlaxoSmithKline (GSK) PLC has announced the acquisition of American Depositary Shares (ADSs) by multiple Independent Non-Executive Directors. These transactions, which took place on the New York Stock Exchange, followed the reinvestment of dividends paid to shareholders on October 10, 2024. All acquisitions were made at a price of $39.0587 per share on October 11, 2024.
For further insights into GB:GSK stock, check out TipRanks’ Stock Analysis page.